The digital pathology market is expected to experience substantial growth, reaching $1.86 billion by 2030, with a compound annual growth rate (CAGR) of 8.7%, according to a recent publication from Meticulous Research®. This growth is primarily driven by factors such as the high prevalence of cancer, increasing research and availability of biomarkers, a growing number of clinical trials in oncology, and the rising demand for accurate detection of genetic and rare diseases. The market's expansion is further supported by the high adoption rate of teleconsulting and the growing focus on precision medicine, particularly in emerging economies.
Download Sample Copy: https://www.meticulousresearch.com/download-sample-report/cp_id=5433
Market Segmentation Insights
The digital pathology market is segmented based on offering, application, end user, and geography, providing a detailed understanding of the industry's future trends.
By Offering: The market is categorized into hardware, software, and services. In 2024, the hardware segment is projected to dominate, largely due to the global burden of chronic diseases and the increasing demand for precise diagnosis and personalized care. This segment includes tissue microarrays, scanners, and other critical hardware components that are essential as pathology becomes more digitalized.
By Application: The application segment is divided into disease diagnosis, drug discovery development, education training, and teleconsultation. The disease diagnosis segment is anticipated to account for the largest market share in 2024, driven by the growing geriatric population, the prevalence of chronic diseases, and the increased use of teleconsulting services post-COVID-19.
By End User: The end user segment includes hospitals clinics, diagnostic laboratories, research institutes academics, and pharmaceutical biotechnology companies. Hospitals clinics are expected to lead the market in 2024, attributed to the high demand for pathological tests, the declining number of pathologists, and ongoing advancements in precision medicine.
Geographical Insights
Regionally, North America is predicted to hold the largest share of the digital pathology market in 2024, followed by Europe and Asia-Pacific. The U.S. is expected to be the dominant player in North America, benefiting from high levels of investment in research and development, rapid adoption of advanced technologies, and a strong demand for reliable and expedited diagnostics.
Buy Now: https://www.meticulousresearch.com/Checkout/83676724
Competitive Landscape
The digital pathology market is highly competitive, with major companies striving to innovate and expand their market presence. Key players include: 3DHISTECH Ltd. (Hungary), Leica Microsystems (a subsidiary of Danaher Corporation) (Germany), Hamamatsu Photonics K.K. (Japan), Nikon Corporation (Japan), Visiopharm A/S (Denmark), Koninklijke Philips N.V.(Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Glencoe Software, Inc. (U.S.), XIFIN, Inc. (U.S.), and PerkinElmer Inc.(U.S.).
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
